Philip J Smith1, J Pekka Nuorti, James A Singleton, Zhen Zhao, Kirk M Wolter. 1. National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, National Immunization Program, MS E-32, 1600 Clifton Rd, NE, Atlanta, GA 30333, USA. pzs6@cdc.gov
Abstract
BACKGROUND: In September 2001 and again in February 2004, the Centers for Disease Control and Prevention announced shortages in the supply of the pneumococcal conjugate vaccine. We describe the effects of the pneumococcal conjugate vaccine shortages in 2001-2003 and 2004 on the timeliness of vaccination uptake for quarterly birth cohorts affected by the shortages. METHODS: A total of 102,478 19- to 35-month-old children were sampled by the National Immunization Survey between 2001 and 2005. Provider-reported vaccination histories were used to evaluate whether children had been administered > or = 4 doses of pneumococcal conjugate vaccine by 16 months of age. RESULTS: Among successive birth cohorts affected by the first shortage, estimated coverage of > or = 4 doses of pneumococcal conjugate vaccine by 16 months declined significantly from 28.8% to 18.2%. As the first shortage ended, estimated coverage of > or = 4 doses of pneumococcal conjugate vaccine by 16 months increased steadily with each successive birth cohort to 40.2%. From the onset of the second shortage, estimated coverage of > or = 4 doses of pneumococcal conjugate vaccine by 16 months declined steadily and significantly to 13.7%. As many as 27% of parents whose child was affected by the first shortage reported that their child's vaccination provider had delayed the administration of pneumococcal conjugate vaccine doses. Of those parents who said that a pneumococcal conjugate vaccine dose was delayed and whose child was not administered > or = 4 doses, 2.9% received a reminder notice from the provider to schedule administration of those delayed doses, and 0.2% had an appointment to receive those delayed or missed doses. CONCLUSIONS: Vaccine shortages can result in delayed or missed doses and can have a dramatic impact on the vaccine coverage of children. Vaccination providers need to communicate effectively with parents so that doses that are delayed or missed during a vaccine shortage are administered when the shortage is resolved.
BACKGROUND: In September 2001 and again in February 2004, the Centers for Disease Control and Prevention announced shortages in the supply of the pneumococcal conjugate vaccine. We describe the effects of the pneumococcal conjugate vaccine shortages in 2001-2003 and 2004 on the timeliness of vaccination uptake for quarterly birth cohorts affected by the shortages. METHODS: A total of 102,478 19- to 35-month-old children were sampled by the National Immunization Survey between 2001 and 2005. Provider-reported vaccination histories were used to evaluate whether children had been administered > or = 4 doses of pneumococcal conjugate vaccine by 16 months of age. RESULTS: Among successive birth cohorts affected by the first shortage, estimated coverage of > or = 4 doses of pneumococcal conjugate vaccine by 16 months declined significantly from 28.8% to 18.2%. As the first shortage ended, estimated coverage of > or = 4 doses of pneumococcal conjugate vaccine by 16 months increased steadily with each successive birth cohort to 40.2%. From the onset of the second shortage, estimated coverage of > or = 4 doses of pneumococcal conjugate vaccine by 16 months declined steadily and significantly to 13.7%. As many as 27% of parents whose child was affected by the first shortage reported that their child's vaccination provider had delayed the administration of pneumococcal conjugate vaccine doses. Of those parents who said that a pneumococcal conjugate vaccine dose was delayed and whose child was not administered > or = 4 doses, 2.9% received a reminder notice from the provider to schedule administration of those delayed doses, and 0.2% had an appointment to receive those delayed or missed doses. CONCLUSIONS: Vaccine shortages can result in delayed or missed doses and can have a dramatic impact on the vaccine coverage of children. Vaccination providers need to communicate effectively with parents so that doses that are delayed or missed during a vaccine shortage are administered when the shortage is resolved.
Authors: Adam L Cohen; Thomas Taylor; Monica M Farley; William Schaffner; Lindsey J Lesher; Kenneth A Gershman; Nancy M Bennett; Arthur Reingold; Ann Thomas; Joan Baumbach; Lee H Harrison; Susan Petit; Bernard Beall; Elizabeth Zell; Matthew Moore Journal: PLoS One Date: 2012-08-01 Impact factor: 3.240
Authors: Lars T Fadnes; Debra Jackson; Ingunn M S Engebretsen; Wanga Zembe; David Sanders; Halvor Sommerfelt; Thorkild Tylleskär Journal: BMC Public Health Date: 2011-05-27 Impact factor: 3.295
Authors: Fabricia Oliveira Saraiva; Ruth Minamisava; Maria Aparecida da Silva Vieira; Ana Luiza Bierrenbach; Ana Lucia Andrade Journal: PLoS One Date: 2015-06-10 Impact factor: 3.240
Authors: Emma Rey-Jurado; Felipe Tapia; Natalia Muñoz-Durango; Margarita K Lay; Leandro J Carreño; Claudia A Riedel; Susan M Bueno; Yvonne Genzel; Alexis M Kalergis Journal: Front Immunol Date: 2018-01-18 Impact factor: 7.561
Authors: Eduardo Suarez-Castaneda; Eleanor Burnett; Miguel Elas; Rafael Baltrons; Lorenzo Pezzoli; Brendan Flannery; David Kleinbaum; Lucia Helena de Oliveira; M Carolina Danovaro-Holliday Journal: Vaccine Date: 2015-08-08 Impact factor: 3.641
Authors: Ruth Link-Gelles; Daniel Westreich; Allison E Aiello; Nong Shang; David J Weber; Corinne Holtzman; Karen Scherzinger; Arthur Reingold; William Schaffner; Lee H Harrison; Jennifer B Rosen; Susan Petit; Monica Farley; Ann Thomas; Jeffrey Eason; Christine Wigen; Meghan Barnes; Ola Thomas; Shelley Zansky; Bernard Beall; Cynthia G Whitney; Matthew R Moore Journal: SSM Popul Health Date: 2016-12
Authors: Ana Lucia Andrade; Eliane T Afonso; Ruth Minamisava; Ana Luiza Bierrenbach; Elier B Cristo; Otaliba L Morais-Neto; Gabriela M Policena; Carla M A S Domingues; Cristiana M Toscano Journal: PLoS One Date: 2017-09-07 Impact factor: 3.240